all press releases

  • 08/08/18
    IRVING, Texas--(BUSINESS WIRE)--Supply chain experts from Vizient, Inc. will be presenting on a range of topics that advance supply chain strategy at the AHRMM18 Conference and Exhibition, August 12-15, in Chicago. The Association for Healthcare Resource & Materials Management (AHRMM) is the premier membership group for healthcare supply chain professionals. Their annual conference offers education and networking opportunities for providers, academics, affiliates andmore...
  • 08/01/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. released today its latest 2018 Drug Price Forecast, which estimates health systems can expect a 4.92 percent increase in the price of pharmaceuticals in 2019. This estimate represents an anticipated slower rate of growth as compared to previous Vizient forecasts, such as the 7.61 percent value projected for 2018. Although the rate of price increases is projected to slow, the specialty pharmacy market ismore...
  • 07/26/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. is disappointed with the recently released Centers for Medicare and Medicaid Services (CMS) annual outpatient prospective payment system (OPPS) proposed rule, specifically those policies related to the 340B Drug Pricing Program and “site-neutral” payments. The 340B Program is critical to America’s safety net, allowing hospitals to provide lifesaving programs to the nation’s most vulnerable patients and communities.more...
  • 07/19/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced it is accepting applications from health care startup companies interested in competing in its sixth annual Innovation Challenge, which will take place October 3 as part of the 2018 Vizient Connections Summit to be held in Las Vegas. Applications are due by 5:00 p.m. CDT on Monday, August 6, 2018. The Innovation Challenge is an interactive competition that offers a unique opportunity for health caremore...
  • 07/18/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. enthusiastically supports the U.S. Food and Drug Administration’s (FDA) newly unveiled 11-part Biosimilar Action Plan (BAP). Vizient has long been a vocal proponent of biosimilar approval, adoption and use and continues to provide education to encourage understanding of this developing market. Vizient endorses FDA’s actions and agrees with its statement that patients “are the primary beneficiaries of this virtuous cycle ofmore...
  • 07/17/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc., today announced the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program available July 1 through September 30, 2018. The National Group Buys program is one of several strategic programs from Vizient designed to deliver additional cost savings to its member hospitals. Siemens Healthineers, the featured supplier for Quarter 3, is offering savingsmore...
  • 07/16/18
    IRVING, Texas--(BUSINESS WIRE)--At a time when rising drug costs are putting an increasing strain on the bottom lines of Vizient member hospitals, we are supportive of efforts by the Administration to understand the complexities of the U.S. pharmaceutical market and look for solutions to curb rising drug costs. Vizient applauds the overall goal of the Department of Health and Human Services’ (HHS) Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs to increasemore...
  • 07/13/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. applauds the U.S. Food and Drug Administration (FDA) for forming a new drug shortages task force and advancing long-term solutions to prevent shortages. Stable and reliable supply, along with cost and safety, are always top priorities for Vizient. In addition to regular communication and education to our health care members, for years we’ve worked to mitigate the impact of shortages and price spikes throughmore...
  • 07/11/18
    IRVING, Texas--(BUSINESS WIRE)--Children who are hospitalized often require specialized devices and drug treatments that are appropriate for their smaller size. To assist providers with insights and education into the latest innovations and technology Vizient has published its latest edition of its Technology Watch series titled, “Emerging Pediatric Technologies”. The report highlights the development of new medical devices for the pediatric patient population, a groupmore...
  • 07/10/18
    IRVING, Texas--(BUSINESS WIRE)--Top oncology stakeholders from across the health care industry are set to meet this week at the MedCity CONVERGE event July 11-12 in Philadelphia. Steven Lucio, associate vice president, pharmacy services, at Vizient will be one of the featured panelists for the session, “Promising Drugs, Pricing and Access” which will focus on the impact of increasingly expensive, novel oncology therapies on the U.S. health care market. The panel willmore...